Adjusting for case under-ascertainment in estimating RSV hospitalisation burden of older adults in high-income countries: a systematic review and modelling study

Y Li, D Kulkarni, E Begier, P Wahi-Singh… - Infectious diseases and …, 2023 - Springer
Introduction Previous studies suggest diagnostic testing characteristics (ie variations in
clinical specimens and diagnostic tests) can contribute to underestimation of RSV disease …

Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-19

E Rice, DB Oakes, C Holland, HC Moore… - Current Opinion in …, 2023 - journals.lww.com
Summary mAbs and maternal vaccines targeting RSV have the potential to reduce
paediatric morbidity, however this new era of RSV prevention will require ongoing research …

[HTML][HTML] Genetic diversity and its impact on disease severity in respiratory syncytial virus subtype-A and-B bronchiolitis before and after pandemic restrictions in Rome

A Pierangeli, R Nenna, M Fracella, C Scagnolari… - Journal of Infection, 2023 - Elsevier
Objectives To scrutinize whether the high circulation of respiratory syncytial virus (RSV)
observed in 2021–2022 and 2022–2023 was due to viral diversity, we characterized RSV-A …

Reconstructing the impact of COVID-19 on the immunity gap and transmission of respiratory syncytial virus in Lombardy, Italy

HJ Ang, F Menegale, G Preziosi, E Pariani, M Migliari… - …, 2023 - thelancet.com
Background Respiratory syncytial virus (RSV) is a leading cause of hospitalisation and
mortality in young children globally. The social distancing measures implemented against …

Respiratory syncytial virus epidemiology and clinical severity before and during the COVID-19 pandemic in British Columbia, Canada: a retrospective observational …

MV Paramo, LPL Ngo, B Abu-Raya… - The Lancet Regional …, 2023 - thelancet.com
Background The COVID-19 pandemic has perturbed the seasonality of respiratory syncytial
virus (RSV) infections. However, we lack data on how this impacted the severity of paediatric …

Respiratory syncytial virus surge in 2022 caused by lineages already present before the COVID‐19 pandemic

M Redlberger‐Fritz, DN Springer… - Journal of Medical …, 2023 - Wiley Online Library
In 2022, Austria experienced a severe respiratory syncytial virus (RSV) epidemic with an
earlier‐than‐usual start (Weeks 35/2021–45/2022) and increased numbers of pediatric …

Atypical age distribution and high disease severity in children with RSV infections during two irregular epidemic seasons throughout the COVID-19 pandemic …

W Cai, S Köndgen, K Tolksdorf, R Dürrwald… - …, 2024 - eurosurveillance.org
Background Non-pharmaceutical interventions (NPIs) during the COVID-19 pandemic
affected respiratory syncytial virus (RSV) circulation worldwide. Aim To describe, for children …

Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor

SM Sake, X Zhang, MK Rajak… - Nature …, 2024 - nature.com
Respiratory syncytial virus (RSV) is a common cause of acute lower respiratory tract
infection in infants, older adults and the immunocompromised. Effective directly acting …

Expert consensus on the diagnosis, treatment, and prevention of respiratory syncytial virus infections in children

XL Zhang, X Zhang, W Hua, ZD Xie, HM Liu… - World Journal of …, 2024 - Springer
Background Respiratory syncytial virus (RSV) is the leading global cause of respiratory
infections and is responsible for about 3 million hospitalizations and more than 100,000 …

Molecular epidemiology and genetic diversity of human respiratory syncytial virus in Sicily during pre-and post-COVID-19 surveillance seasons

F Tramuto, CM Maida, W Mazzucco, C Costantino… - Pathogens, 2023 - mdpi.com
Human respiratory syncytial virus (hRSV) is an important pathogen of acute respiratory tract
infection of global significance. In this study, we investigated the molecular epidemiology …